Rivastigmine metabolite (NAP 226-90) is a metabolite produced by the hydrolysis of Rivastigmine ( HY-17368 ) . Rivastigmine metabolite serves as a surrogate marker to track the bioavailability, metabolic extent, and transdermal patch delivery rate of Rivastigmine .
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Others | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Alzheimer's Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Research Areas > Others | Products > Signaling Pathways > Drug Metabolite
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。